Adobe's Substance 3D Designer introduces a new 3D render engine which blends raster and path tracing capabilities into a unified architecture. All in all, Substance 3D Designer v15 is a fairly ...
In drug discovery, the recipe for success has long called for ingredients such as experience, chemistry and biology know-how, technology, and, of course, perseverance. Over the years, however, many ...
Artificial intelligence-based drug molecule designer XtalPi has secured a mammoth series C funding round totaling $318.8 million, raised from global investment companies across the banking and ...
Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 9, 2023) - PurMinds NeuroPharma ("PurMinds™" or the "Company"), a clinical-stage neuroscience company focused on neurological and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback